1. Yazawa, Takashi, Imamichi, Yoshitaka, Kitano, Takeshi, Umezawa, Akihiro, Uwada, Junsuke. 2023. Expression of Chrna9 is regulated by Tbx3 in undifferentiated pluripotent stem cells. In Scientific reports, 13, 1611. doi:10.1038/s41598-023-28814-7. https://pubmed.ncbi.nlm.nih.gov/36709241/
2. Hsieh, Yi-Chen, Lee, Chia-Hwa, Tu, Shih-Hsin, Ho, Yuan-Soon, Chiou, Hung-Yi. 2014. CHRNA9 polymorphisms and smoking exposure synergize to increase the risk of breast cancer in Taiwan. In Carcinogenesis, 35, 2520-5. doi:10.1093/carcin/bgu179. https://pubmed.ncbi.nlm.nih.gov/25142973/
3. Ma, Xiaoshan, Geng, Ren, Zhao, Yao, Zhao, Liyan, Li, Yunqian. 2024. CHRNA9 as a New Prognostic Marker and Potential Therapeutic Target in Glioma. In Journal of Cancer, 15, 2095-2109. doi:10.7150/jca.92080. https://pubmed.ncbi.nlm.nih.gov/38495483/
4. Munoz, Felipe, Vicencio-Jimenez, Sergio, Jorratt, Pascal, Delano, Paul H, Terreros, Gonzalo. 2022. Corticofugal and Brainstem Functions Associated With Medial Olivocochlear Cholinergic Transmission. In Frontiers in neuroscience, 16, 866161. doi:10.3389/fnins.2022.866161. https://pubmed.ncbi.nlm.nih.gov/35573302/
5. Huynh, Peter N, Christensen, Sean B, McIntosh, J Michael. 2022. RgIA4 Prevention of Acute Oxaliplatin-Induced Cold Allodynia Requires α9-Containing Nicotinic Acetylcholine Receptors and CD3+ T-Cells. In Cells, 11, . doi:10.3390/cells11223561. https://pubmed.ncbi.nlm.nih.gov/36428990/
6. Briggs, Farren Bs. 2020. Nicotinic acetylcholine receptors α7 and α9 modifies tobacco smoke risk for multiple sclerosis. In Multiple sclerosis (Houndmills, Basingstoke, England), 27, 1166-1174. doi:10.1177/1352458520958361. https://pubmed.ncbi.nlm.nih.gov/32924781/
7. Chikova, Anna, Bernard, Hans-Ulrich, Shchepotin, Igor B, Grando, Sergei A. 2012. New associations of the genetic polymorphisms in nicotinic receptor genes with the risk of lung cancer. In Life sciences, 91, 1103-8. doi:10.1016/j.lfs.2011.12.023. https://pubmed.ncbi.nlm.nih.gov/22280835/